Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Keppra XR pharmacokinetic study in adolescents and adults with epilepsy
2014-004376-39Phase 2
- Sponsor
- UCB
- Start
- Feb 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label trial of levetiracetam in epilepsy (2 arms), sponsored by UCB. Primary endpoint: Maximum concentration at steady state normalized by dose and by body weight and dose.
02
Drugs
levetiracetam
03
Conditions
epilepsy
Beyond the preview
Go deeper on 2014-004376-39.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2014-004376-39.